CORCEPT THERAPEUTCS (HTD BE) stock market data APIs
€59.7463
0(0%)
as of July 3, 2025
Try our APIs with
free plan!
CORCEPT THERAPEUTCS Financial Data Overview
Price chart is built with
Anychart
There is no Profile data available for HTD.BE.
Prev. Close
59.7463
Open
59.7463
High
59.7463
Low
59.7463
52 wk Range
27.04-105.2
Market Cap
1 917 M
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get CORCEPT THERAPEUTCS data using free add-ons & libraries
Get CORCEPT THERAPEUTCS Fundamental Data
CORCEPT THERAPEUTCS Fundamental data includes:
- Net Revenue:
- EBITDA:
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: NaN
- EPS/Forecast: NaN
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
CORCEPT THERAPEUTCS News
New
Corcept Therapeutics (NasdaqCM:CORT) Dropped From Russell 2000 and Growth Index
Corcept Therapeutics recently saw a decline in its share price by 1.43% over the last week. This price movement occurred against a backdrop of the company's removal from the Russell 2000 and Russell 2...
5 Insightful Analyst Questions From Corcept’s Q1 Earnings Call
Corcept’s first quarter results were met with a negative market reaction, as management cited operational disruptions at a key pharmacy vendor and a shift in product mix as reasons for underwhelming...
Corcept ALS Drug Shows Significant Survival Benefit Despite Missed Primary Endpoint
Corcept Therapeutics Incorporated (NASDAQ:CORT) is one of the best mid cap growth stocks to invest in now. Earlier on June 5, Corcept Therapeutics presented detailed results from its Phase 2 DAZALS st...
Corcept Presents Data from Treatment Phase of CATALYST Trial at American Diabetes Association’s 85th Scientific Sessions with Simultaneous Publication in Diabetes Care
Treatment with a cortisol modulator significantly improves glucose control in patients with hypercortisolism and difficult-to-control diabetes, accompanied by reductions in body weight, waist circumfe...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
